《泌尿腫瘤學(xué)》致力于覆蓋泌尿生殖系統(tǒng)癌癥的各個(gè)方面。該雜志將發(fā)表實(shí)驗(yàn)室和診所的原始研究論文、評(píng)論文章和爭(zhēng)議討論。醫(yī)生和科學(xué)家都應(yīng)該在遺傳學(xué)和細(xì)胞生物學(xué)、最新開(kāi)發(fā)的診斷技術(shù)以及泌尿腫瘤廣泛領(lǐng)域治療方法的變化等主題中找到實(shí)用和具有啟發(fā)性的讀物。目標(biāo)受眾是國(guó)際性和多學(xué)科的，旨在包括泌尿科醫(yī)師、腫瘤內(nèi)科醫(yī)師、放射腫瘤學(xué)家、病理學(xué)家、細(xì)胞和分子生物學(xué)家、遺傳學(xué)家以及在該領(lǐng)域工作或感興趣的任何臨床醫(yī)師或調(diào)查員。該雜志的主要目標(biāo)是在實(shí)驗(yàn)室和臨床上利用多學(xué)科的基礎(chǔ)來(lái)激發(fā)新的想法和研究，以解決影響泌尿生殖系統(tǒng)的各種腫瘤問(wèn)題。

Urologic Oncology is dedicated to the coverage of all aspects of cancers of the genitourinary system. The journal will publish original research papers from the laboratory and the clinic, review articles, and discussions of controversies. Physicians and scientists alike should find both practical and provocative reading in topics ranging from genetics and cell biology, newly developed diagnostic techniques, and changing approaches to treatment in the broad field of urologic oncology. The target audience is international and multidisciplinary, and is designed to include urologists, medical oncologists, radiation oncologists, pathologists, cell and molecular biologists, geneticists and any clinician or investigator working in or having an interest in this field. The journal's major objective is to stimulate new ideas and research with a multidisciplinary base in both the laboratory and in the clinic of the various problems in oncology that affect the genitourinary system.